GlobeNewswire

Jumio Records Best Sales Quarter in Company History, Fueled by Q2 Growth in Asia Pacific

Dela

Jumio Records Best Sales Quarter in Company History, Fueled by Q2 Growth in Asia Pacific

Jumio's sales grew by more than 200 percent year over year for three of our last four quarters; the company has recorded quarter over quarter sales growth nine of the last ten quarters

PALO ALTO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Jumio, the leading AI-powered trusted identity as a service provider, today announced its best sales quarter in company history, ending June 30, 2018, representing a 269 percent increase in sales over the same quarter last year. The results were fueled by record sales growth in the Asia Pacific region, which grew 531 percent over the previous quarter.

"We're thrilled that within three months of opening our Singapore office, Asia Pacific has already generated so much in sales and has seen such wide adoption," said Steve Stuut, CEO of Jumio. "This type of immediate market traction speaks to the opportunity this region represents and the untapped potential, especially within financial services, enterprise and e-commerce markets."

The emerging need for reliable digital identity verification, coupled with increasingly stringent data protection and privacy regulations (e.g., GDPR and California Consumer Privacy Act) and the growing realization that traditional authentication methodologies are no longer effective or secure, has caused companies to explore the identity-verification-as-a-service market.

According to a market study by McKinsey, the emerging identity-verification-as-a-service market is close to $10 billion and predicts it will grow to a $16-20 billion market by 2022. McKinsey reports, "Identity verification-as-a-service offers a way for e-commerce providers to outsource the verification function to providers with the necessary scale and security to accomplish sensitive transactions quickly, safely, and efficiently." In fact, the Asia Pacific market is growing almost 50 percent faster than the North America and Western European markets because of the higher volume of digital transactions that require online identity verification.

Increased awareness and familiarity with identity verification has helped fuel Jumio's continued momentum as the company reports its strongest quarter in company history, including these notable milestones:

  • Six Straight Quarters of Sales Growth: Jumio grew sales nine of the past ten quarters, demonstrating growing traction for its online ID and identity verification solutions. Its focus on compliant machine learning, leading-edge identity proofing technologies, and a customer-centric mentality have helped Jumio set the bar for online identity verification accuracy and gain significant market share.
  • AsiaPac Expansion: In Q2, Jumio saw its Asia Pacific sales grow significantly and signed two of the largest deals in the company's history as a result of having a dedicated regional focus, which includes a new Singapore office and expanded sales presence to support the region's growing demand for online digital identity verification and Know Your Customer (KYC) services. 
  • Liveness Detection for Web: Jumio launched Liveness Detection for Web to ensure that the online user is physically present during the identity verification process when using their computer's webcam. This new functionality requires the user to take a picture of themself holding a handwritten note with a custom phrase (e.g. company name) and the current date, to ensure a real person is performing the transaction. 
  • Executive Hires: In Q2, Jumio hired several new executives to further strengthen its leadership team and support its aggressive growth objectives, including: Miles Hutchinson, Chief Information Security Officer; Mike O'Callaghan,Vice President Global Operations; and Amy Treadwell, Global Vice President of People and Culture. Together, the three new hires bring decades of leadership experience in high-growth SaaS and technology organizations.
  • Industry Recognition: Jumio continues to be recognized for its product innovation, including being awarded the Gold winner in Information Security and Risk Management (and Bronze winner for Security Software) in the 13th Annual 2018 IT World Awards®, named Best Product in Biometrics and Hot Company in Fraud Prevention by the 2018 InfoSec Awards, and named the winner in the Best Authentication Technology category by the 2018 SC Awards. Jumio was also included as a Representative Vendor in the "Market Guide for Identity Proofing and Corroboration," published by Gartner, a leading information technology research and advisory company.

For live demonstrations of the Netverify ID, Identity and Document Verification solutions, visit Jumio at the iGB Live show (Stand T7) this month in Amsterdam.

About Jumio
When identity matters, trust Jumio. Jumio is the creator of Netverify® which enables businesses to increase customer conversions while providing a seamless customer experience and reducing fraud. By combining the three core pillars of ID Verification, Identity Verification and Document Verification, businesses now have a complete solution that allows them to establish the real-world identity of the consumer.

Leveraging advanced technology including augmented AI, biometric facial recognition, machine learning, and human review, Jumio helps organizations to meet regulatory compliance including KYC, AML and GDPR and definitively establish the digital identity of their customers. Jumio has verified more than 120 million identities issued by over 200 countries from real time web and mobile transactions. Jumio's solutions are used by leading companies in the financial services, sharing economy, cryptocurrency, retail, travel and online gaming sectors. Based in Palo Alto, Jumio operates globally with offices in the US, Europe, and Asia Pacific and has been the recipient of numerous awards for innovation. For more information, please visit www.jumio.com.

Media Contacts
U.S. Media Contact
Jackie Daane
10Fold Communications
Jumio@10fold.com
415-800-5369

Europe Media Contact
Zarina Banu
FleishmanHillard Fishburn
zarina.banu@fhflondon.co.uk
+44 (0) 7775 557578

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d1c780f4-0c16-40b0-acea-f900be5545a4




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Jumio Corp. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum